01 / DESIGN
What was studied?
Female rats modeling obesity-related heart failure were studied using muscle-force tests, mitochondrial measurements and tissue analyses.
02 / FINDINGS
What did the researchers report?
Elamipretide was associated with improvement in selected whole-muscle and single-fiber measurements alongside changes in mitochondrial and contractile markers.
03 / LIMITS
How should it be interpreted?
The findings concern a particular animal model and isolated-muscle endpoints. They do not establish exercise benefits in people with heart failure or ordinary healthy users.
Voltera Peptide editorial reading note. Based on the linked source record. Methods and corrections.